AstraZeneca Group (AZN)

41.23 +0.05  +0.12%  May 25, 11:00PM Go Pro
Watch this stock

AstraZeneca Group Tangible Common Equity Ratio: 2.76%

Get Interactive Chart for

View AZN Tangible Common Equity Ratio with YCharts Pro.




Start My 14-Day Free Trial We respect your privacy. We will never share your email address.
document.write('');

Access these YCharts Pro features:

  • Export any data you want
  • Save any chart as an image
  • Utilize advanced screener power
  • View 30 years of financial history
  • over 90 advanced calculations
  • Enjoy an advertising free experience
and much more...

AZN Tangible Common Equity Ratio Rankings

Overall 84th percentile 666 of 4385
Sector 81st percentile 92 of 504 in Healthcare
Industry 72nd percentile 7 of 25 in Drug Manufacturers - Major

AZN Tangible Common Equity Ratio Range, Past 5 Years

Minimum -36.18% Mar 2008
Maximum 8.44% Sep 2011
Average -10.46%

About Tangible Common Equity Ratio

The tangible common equity (TCE) ratio is a useful number to gauge leverage of a financial firm. Specifically, it answers the question: "How much can the value of a bank's assets fall before the entire value of tangible* common equity is wiped out?"

For example, assume a bank as a TCE ratio of 5%. If the value of all of the banks assets fell by 5%, theoretically stockholders would no longer have a claim on the bank's tangible assets.

Another way of thinking about the TCE ratio of 5% is that the remaining 95% of the bank's tangible assets have been purchased using loaned funds that the bank must repay.

This ratio is worth spending time with. Once investors understand its implications, they rarely look at banking businesses the same way.

* The word tangible, in accounting, essentially means anything that can be touched or traded. Cash, buildings, accounts receivable, inventories and stock holdings of a business are all tangible assets. Trade secrets, patents, copyrights, and goodwill are not tangible assets, even though they may have value.
Learn More

AZN News

$AZN stop at 40 on 1/3. Have owned a ton of it since early '10. Cost basis ~46 (not inc. divies)
about 4 days ago by WallStreetBean
Why U.K. Bonds Are for Losers
May 17, 6:07PM Fool
RT @SeemaCnbc Cancer data expected to move big pharma $JNJ $PFE $AZN
about 10 days ago by StockTwits
$AMRN chat of potential take over target by $AZN for sometimes
about 12 days ago by tradeha
Avoid These 2 Plunging Biotechs
May 14, 5:30PM Fool
$AZN “no longer operating in isolation as a pharmaceutical organization.” http://stks.co/3nwQ
about 14 days ago by WallStreetBean
[$$] 13D Filings
May 12, 4:42AM
6 Flatlining Healthcare Stocks to Sell
May 09, 12:45PM Investor Place
$AMRN and $FRX both are possible acquisition targets for $AZN
about 19 days ago by tradeha
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 20 days ago by abubnic
$AMRN U.K.'s second-biggest drugmaker, pharmaceutical giant $AZN, based in London is sniffing around Ireland's small biotech $AMRN
about 23 days ago by JasonMilano8
$AMRN Bloomberg: Amarin takeover target by AstraZeneca $AZN
about 23 days ago by JasonMilano8
Health Care Sector Wrap
May 03, 4:48PM Fox Business
$AZN popping
about 24 days ago by AltecBX
$AZN a look at last 3 years Annual data: http://stks.co/3cDp
about 26 days ago by WallStreetBean
News related to $AZN, currently +0.3% since open: 'Impax Labs falls on weak sales, new FDA warning' http://stks.co/3bhx
about 26 days ago by TradeBot
what kinda drug is that? RT @JNapodano $AZN reported $16M in sales of Vimovo - not great, but still higher than consensus. $POZN.
about 27 days ago by WallStreetBean
$azn....the yield on this bio just crossed 8.5%....
about 31 days ago by Higreg
$AZN Volume Alert - Currently at 5 x average daily volume.
about 31 days ago by TradeIdeasQuant
5% movers over 10B mkt cap. Up $CTXS $ECA $REGN - Down $AET $AZN $GG Will post charts.
about 31 days ago by TheNumb47
Morning News: April 26, 2012 | via @EddyElfenbein http://stks.co/3Wht $FED $DB $NDX $AAPL $CAT $AZN
about 31 days ago by STNet
$AZN trouble in paradise: AstraZeneca CEO to step down as Q1 profit plunges http://stks.co/3WZ3 (holding)
about 31 days ago by WallStreetBean
News related to $AZN: 'AstraZeneca CEO to step down as Q1 profit plunges' http://stks.co/3WIC
about 32 days ago by TradeBot
$AZN Thurs am eps one of MANY - consensus $1.73 vs 2.03
about 32 days ago by MinervasMomma
$AMRN $azn Will buy $amrn it is just Time 10$ no thanks I will need over 20 to Sell.
about 32 days ago by RqTect
$AMRN $azn does not just want $amrn They need AMRN that is why it is going to $22
about 32 days ago by RqTect
@taketheplunge $AMRN $AZN has been linked to every biotech on the market in the last 3 months. $AZN could buy...
about 32 days ago by jackofalltrade

Recent Quotes

Symbol Price Chg Chg % Market Cap
AZN 41.23 +0.05 +0.12% 53.28B
AZK 4.72 +0.11 +2.39% 769.97M
AZC 1.63 +0.13 +8.67% 235.05M
AYR 11.60 +0.37 +3.29% 839.61M
BCRX 3.26 +0.00 +0.00% 150.09M
BCR 99.90 -0.09 -0.09% 8.473B
BCPC 30.31 -0.25 -0.82% 885.36M
BCOM 4.20 +0.01 +0.24% 125.54M
BCO 23.23 -0.32 -1.36% 1.089B
BCH 84.05 +0.83 +1.00% 12.18B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close